Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. 1 dose (1 ml)
Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →
News topic
Current shortage notices for the ATC group J07BC01, structured by product, country and reporting period.
4 noticesActive ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →Active ingredient: Hepatitis-B-Impfstoff (rekombinant, adjuvantiert)
View notice details →Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →